• Study on Early Breast Cancer Treatment with Palbociclib, Tamoxifen, and Exemestane for Patients with Estrogen Receptor Positive Tumors

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Sweden

  • Study on Esflurbiprofen Topical System and Paracetamol for Pain Relief in Patients with Acute Ankle Sprains

    Not recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Germany

  • Study on Cannabidiol for Reducing Anxiety and PTSD Symptoms in Dutch Uniformed Personnel

    Not recruiting

    2 1
    Investigated Diseases:
    Investigated Drugs:
    The Netherlands

  • Study on Amitriptyline and Cognitive Behavioral Therapy for Patients with Chronic Insomnia and Medical Conditions

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    The Netherlands

  • Study on Paracetamol and Strong Opioids for Pain Relief in Patients with Metastatic Cancer

    Not recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Norway

  • Study Comparing Sacituzumab Govitecan with Other Treatments for Patients with Advanced Unresectable Urothelial Cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium France Germany Greece Ireland Italy +2

  • Study on the Effectiveness and Safety of Nofazinlimab and Lenvatinib for Patients with Advanced Liver Cancer

    Not recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Poland Spain

  • Study on EHSG-KF for Treating Partial Deep Dermal and Full Thickness Burns in Adults and Adolescents

    Not recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    The Netherlands

  • Study on the Impact of DPYD Gene Test on the Safety and Efficacy of Fluorouracil, Capecitabine, and Tegafur in Finnish Patients with Breast or Colon Cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Finland

  • Study on the Effectiveness and Safety of Luspatercept for Patients with Lower-Risk Myelodysplastic Syndromes Requiring Red Blood Cell Transfusions

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    Austria Germany Spain

powered by